BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34181162)

  • 1. SMARCA4-deficient thoracic tumor detected by [
    Okazaki T; Yokoyama K; Tsuchiya J; Honda T; Ishikawa Y; Kirimura S; Miyazaki Y; Tateishi U
    Eur J Hybrid Imaging; 2021 Apr; 5(1):8. PubMed ID: 34181162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG PET/CT in a Case of Thoracic SMARCA4-Deficient Undifferentiated Tumor.
    Guo J; Liao Z; Chen Q; Dong A; Huang M
    Clin Nucl Med; 2023 Dec; 48(12):1111-1113. PubMed ID: 37882056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic and Static
    Wumener X; Ye X; Zhang Y; Jin S; Liang Y
    Diagnostics (Basel); 2023 Jun; 13(12):. PubMed ID: 37370943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMARCA4-deficient tumors in the adrenal gland and small intestines: A rare case report.
    Kambe A; Yamamoto Y; Hasegawa C; Kakiuchi A; Kojima D; Hino A; Horikawa A; Doiuchi T; Kurihara H
    Radiol Case Rep; 2024 Feb; 19(2):794-797. PubMed ID: 38111549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thoracic SMARCA4-Deficient Undifferentiated Tumor Mimicking a Pleural Mesothelioma on 18F-FDG PET/CT.
    Chen X; Chen G; Li Q; Fu Z
    Clin Nucl Med; 2024 May; ():. PubMed ID: 38768095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A first described chest wall metastasis from colon cancer demonstrated with (18)F-FDG PET/CT.
    Jiang L; Gao Y; Sheng S; Xu M; Lu L; Lu H
    Hell J Nucl Med; 2011; 14(3):316-7. PubMed ID: 22087459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An assessment of
    So A; Pointon O; Hodgson R; Burgess J
    Clin Endocrinol (Oxf); 2018 May; 88(5):683-691. PubMed ID: 29446832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging features of SMARCA4-deficient thoracic sarcomas: a multi-centric study of 21 patients.
    Crombé A; Alberti N; Villard N; Pilleul F; Buy X; Le Loarer F; Kind M
    Eur Radiol; 2019 Sep; 29(9):4730-4741. PubMed ID: 30762113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thoracic SMARCA4-deficient undifferentiated tumor resembling malignant lymphoma].
    Asou C; Maeda T; Yamaguchi O; Okamura D; Ishikawa M; Kohri M; Tsukasaki K; Matsuda A; Asou N; Satoh T; Kayano H; Takahashi N
    Rinsho Ketsueki; 2023; 64(4):271-276. PubMed ID: 37121771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
    Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
    Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Liu C; Gong C; Liu S; Zhang Y; Zhang Y; Xu X; Yuan H; Wang B; Yang Z
    Oncologist; 2019 Dec; 24(12):e1277-e1285. PubMed ID: 31337657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo quantification of pulmonary inflammation in relation to emphysema severity via partial volume corrected (18)F-FDG-PET using computer-assisted analysis of diagnostic chest CT.
    Torigian DA; Dam V; Chen X; Saboury B; Udupa JK; Rashid A; Moghadam-Kia S; Alavi A
    Hell J Nucl Med; 2013; 16(1):12-8. PubMed ID: 23529388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
    Ak I; Sivrikoz MC; Entok E; Vardareli E
    Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMARCA4-deficient non-small cell lung carcinoma: clinicodemographic, computed tomography, and positron emission tomography-computed tomography features.
    Kim JH; Woo JH; Lim CY; An T; Han J; Chung MJ; Cha YK
    J Thorac Dis; 2024 Mar; 16(3):1753-1764. PubMed ID: 38617754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers.
    Ulaner GA; Goldman DA; Gönen M; Pham H; Castillo R; Lyashchenko SK; Lewis JS; Dang C
    J Nucl Med; 2016 Sep; 57(9):1350-6. PubMed ID: 26940766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Outcome of Lung Nodules Missed on 18F-FDG PET/MRI Compared with 18F-FDG PET/CT in Patients with Known Malignancies.
    Sawicki LM; Grueneisen J; Buchbender C; Schaarschmidt BM; Gomez B; Ruhlmann V; Umutlu L; Antoch G; Heusch P
    J Nucl Med; 2016 Jan; 57(1):15-20. PubMed ID: 26514173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidentally Detected
    Meyer AR; Leroy A; Allaf ME; Rowe SP; Gorin MA
    J Endourol Case Rep; 2019; 5(2):68-70. PubMed ID: 32760804
    [No Abstract]   [Full Text] [Related]  

  • 19. Imaging performance of thoracic SMARCA4-deficient undifferentiated tumor: a case report and literature review.
    Yang D; Wang Y
    Transl Lung Cancer Res; 2024 Feb; 13(2):443-452. PubMed ID: 38496696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.
    Hogan MP; Goldman DA; Dashevsky B; Riedl CC; Gönen M; Osborne JR; Jochelson M; Hudis C; Morrow M; Ulaner GA
    J Nucl Med; 2015 Nov; 56(11):1674-80. PubMed ID: 26294295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.